| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |